Embecta Corporation share price logo

Embecta Corporation

NASDAQ: EMBC

Small Cap

$6.25

-0.31

(-4.73%)

as on

Embecta Corporation Stock Performance

as on October 31, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $6.20
    $6.54
    downward going graph

    0.80%

    Downside

    4.64%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $2.77
    $14.91
    downward going graph

    55.68%

    Downside

    138.56%

    Upside

    downward going graph

Embecta Corporation share price movements today

Previous Close
$6.56
Open
$6.50
Volume
750.3K
Market Cap
$366.0M
Dividend Yield
4.95%
Day's Low - High
$6.20 - $6.54
52 Week Low - High
$2.77 - $14.91

Embecta Corporation Historical Returns

1 Month Return
+ 15.9 %
3 Month Return
+ 79.23 %
1 Year Return
-51.98 %
3 Year Return
-56.98 %
5 Year Return
0 %

Embecta Corporation Stock Fundamentals & Key Indicators

Check Embecta Corporation market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$366.0M

EPS (TTM)

1.49

Dividend Yield

4.95%

Quarterly Earnings Growth YOY

-0.54%

PE Ratio (TTM)

4.34

Industry PE ratio

13.43

PEG Ratio

0.88

EBITDA

265.9M

Revenue (TTM)

1.0B

Profit Margin

59.89%

Return On Equity TTM

-13.98%

Embecta Corporation vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Embecta Corporation with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Sell$366.0MNA4.3459.89%4.95%
Neutral$35.2B-3.83%23.9661.16%0.98%
StrongBuy$156.9B24.27%53.0767.19%0.00%
Neutral$52.8B-18.89%58.5446.12%2.05%
StrongBuy$43.6BNA37.6425.02%0.00%

Stock Returns calculator for Embecta Corporation Stock including INR - Dollar returns

The Embecta Corporation stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Embecta Corporation investment value today

Current value as on today

₹48,965

Returns

-₹51,035

(-51.04%)

Returns from Embecta Corporation Stock

-₹54,246 (-54.25%)

Dollar Impact

₹3,211 (+3.21%)

Analyst Recommendation on Embecta Corporation Stock

Based on 1 analysts

SELL

0.00%

Buy

0.00%

Hold

100.00%

Sell

Based on 1 analysts, 100% of analysts recommend a 'SELL' rating for Embecta Corporation. Average target price of $4

Embecta Corporation Share Price Target

Get share price movements and forecasts by analysts on Embecta Corporation.

What analysts predicted

-56.25%DOWNSIDE

Target Price

$4

Current Price

$6.25

Analyzed by

1 Analysts

Target

$4.00

Embecta Corporation target price $4, a slight downside of -56.25% compared to current price of $6.25. According to 1 analysts rating.

Indian Investors' Interest in Embecta Corporation Stock

Search interest for Embecta Corporation Stock has increased by 85% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:85% versus previous 30 day period

Embecta Corporation Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
287
272
286
261
259
295
264
261
221
271
Gross Profit
184
187
171
166
161
195
156
175
125
153
Operating Income
39
55
33
76
78
106
64
97
42
48
EBITDA
47
65
27
39
74
110
60
95
44
64
Interest Expense
27
27
29
27
26
26
26
24
22
23
Depreciation
10
11
5
11
11
11
5
12
12
13
Income Before Tax
9
27
-7
0
35
72
29
58
9
27
Income Tax Expense
-19
12
-21
0
12
26
2
14
13
6
Net Income
28
14
14
0
23
45
26
44
-4
21
Net Profit Margin
64.14%
69.76%
59.87%
63.73%
62.36%
65.99%
59.09%
67.23%
56.45%
56.42%

Embecta Corporation Annual Profit & Loss

All numbers in Millions USD

Sep 2019
Sep 2020
Sep 2021
Sep 2022
Sep 2023
Sep 2024
Sep 2025
Total Revenue
1,109
1,085
1,165
1,129
1,120
1,123
1,080
Gross Profit
786
763
800
774
749
728
679
Operating Income
502
487
492
378
229
174
329
EBITDA
536
524
533
334
245
192
284
Interest Expense
-
-
-
46
107
112
107
Depreciation
36
38
38
31
32
36
40
Income Before Tax
500
485
495
256
105
44
136
Income Tax Expense
68
58
80
33
35
-34
40
Net Income
432
427
414
223
70
78
95
Net Profit Margin
70.87%
70.25%
68.67%
68.61%
66.91%
64.90%
62.89%

Embecta Corporation Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
28
14
14
-
23
45
26
44
-4
21
Operating Cash Flow
24
-2
26
-5
31
81
84
17
31
41
Investing Cash Flow
-3
-9
-
-1
0
0
-7
9
0
-129
Financing Cash Flow
-11
-11
-36
-45
-37
-62
-81
-51
-41
112
Change in Cash
7
-24
-7
-57
-4
21
-5
-24
-11
24

Embecta Corporation Annual Cash Flow

All numbers in Millions USD

Sep 2019
Sep 2020
Sep 2021
Sep 2022
Sep 2023
Sep 2024
Sep 2025
Net Income
432
427
415
223
70
78
95
Operating Cash Flow
505
498
456
412
67
35
191
Investing Cash Flow
-69
-41
-39
-24
-26
-15
-9
Financing Cash Flow
-436
-456
-417
-48
-48
-73
-226
Change in Cash
-
-
-
330
-4
-52
-45

Global Institutional Holdings in Embecta Corporation

Check out the Institutions with significant holdings in Embecta Corporation.

Funds
Holdings
Donald Yacktman
7.62%
AMG Funds
6.18%
Vanguard
6.06%
James E. Flynn
4.47%
VANGUARD INDEX FUNDS
4.41%

Embecta Corporation News & Key Events

  • img

    Today's Timeline - 09 August

    Mon, 00:20 AM

    -

    Embecta faces class action lawsuit over alleged misrepresentation of its insulin pen needle business stability.

    Mon, 05:35 AM

    -

    Embecta's Q3 earnings call reveals strategic wins but significant U.S. revenue declines, raising concerns about future performance.

Insights on Embecta Corporation

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -4.1M → 21.10M (in $), with an average increase of 119.4% per quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 221.79M → 271.69M (in $), with an average increase of 18.4% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, EMBC stock has moved up by 80.2%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Embecta Corp. Common Stock has experienced a drawdown of -56.8%, however ResMed Inc. resisted the overall trend and outperformed by 35.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Becton, Dickinson and Co. has given 11.0% return, outperforming this stock by 61.8%

About Embecta Corporation

Embecta Corp. is a medical technology enterprise devoted to enhancing the quality of life and health outcomes for individuals living with diabetes. Its comprehensive product portfolio includes essential tools such as pen needles, syringes, and advanced safety devices. Additionally, the company provides innovative digital applications designed to support patients in effectively managing their condition. Embecta distributes its offerings primarily through a network of wholesalers and distributors, reaching markets both domestically within the United States and across the globe. Established in 1924, Embecta's headquarters are located in Parsippany, New Jersey. The company transitioned to an independent entity from Becton, Dickinson and Company on April 1, 2022.
OrganisationEmbecta Corporation
Headquarters300 Kimball Drive, Parsippany, NJ, 07054, US
IndustryMedical - Instruments & Supplies
CEODevdatt Kurdikar

Key Management of Embecta Corporation

Name

Title

Mr. Devdatt Kurdikar Ph.D.

President, CEO & Chairman

Mr. Jacob P. Elguicze

Senior VP & CFO

Mr. Jeffrey Z. Mann

Senior VP, General Counsel, Head of Business Development & Corporate Secretary

Ms. Jean M. Casner

Senior VP & Chief Human Resources Officer

Mr. Shaun Curtis

Senior Vice President of Global Manufacturing & Supply Chain

Mr. Pravesh Khandelwal

VP & Head of Investor Relations

Ms. Ginny Blocki

Senior Vice President of Strategy

Mr. Tom Blount

Senior VP & President of North America

Mr. Slobodan Radumilo

Senior VP & President of International

Mr. Anthony M. Roth

VP, Chief Accounting Officer & Corporate Controller

FAQs

What is Embecta Corporation share price today?

Embecta Corporation share price today is $6.25 as on at the close of the market. Embecta Corporation share today touched a day high of $6.54 and a low of $6.20.

What is the 52 week high and 52 week low for Embecta Corporation share?

Embecta Corporation share touched a 52 week high of $14.91 on and a 52 week low of $2.77 on . Embecta Corporation stock price today i.e. is closed at $6.25,which is 58.08% down from its 52 week high and 125.63% up from its 52 week low.

What is Embecta Corporation's market capitalisation today?

Embecta Corporation market capitalisation is $0.00T as on .

How to invest in Embecta Corporation Stock (EMBC) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Embecta Corporation on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Embecta Corporation Stock (EMBC) from India?

Indian investors can start investing in Embecta Corporation (EMBC) shares with as little as ₹94.94999694824219 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.50 in Embecta Corporation stock (as per the Rupee-Dollar exchange rate as on ). Based on Embecta Corporation share’s latest price of $6.25 as on October 31, 2026 at 8:46 am IST, you will get 1.6000 shares of Embecta Corporation. Learn more about fractional shares .